Objectives. To study the effects of Cytoflavin during the recovery period of ischemic stroke (IS) in terms of changes in neuropsychological status and serum levels of neurotrophins. Materials and methods. A total of 52 patients were observed after fi rst IS at age 52–74 years. Patients were divided into two groups. The study group (25 patients) received basal therapy supplemented with intravenous Cytoflavin infusions of 20 ml in 400 ml of 5% glucose solution once daily for 10 days followed by two tablets twice daily half an hour before meals for one month. The reference group (27 patients) received standard treatment. The control group consisted of 12 essentially healthy subjects. Apart from standard clinical laboratory investigations, participants underwent complex neuropsychological studies with assessment of data on the NIHSS, Bartel, Beck, and Spilberger–Hanin tests, the Frontal Assessment Battery, and the Mini Mental State Examination. In addition, neurotrophic factor levels were determined: nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Studies were performed over time: before treatment started and two months after treatment. Results and conclusions. Patients in the recovery period following first IS showed moderate impairments to neuropsychological status and decreases in neurotrophic factor levels. Prescription of Cytoflavin increased treatment efficacy, which was apparent as a more marked improvement in neurological symptomatology as compared with the results obtained with basal therapy, along with improvements in cognitive functions and increases in BDNF levels. Efficacy and safety data indicate that Cytoflavin can be included in treatment schemes for patients in the recovery period following first carotid IS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
B. S. Vilenskii, Current Tactics in the Battle against Stroke, Foliant, St. Petersburg (2005).
E. I. Gusev and P. R. Kamchatnov, “Plasticity of the nervous system,” Zh. Nevrol. Psikhiat., No. 3, 73–79 (2004).
V. I. Skvortsova, “Decreases in morbidity, mortality, and disability due to stroke in the Russian Federation,” in: Collection of Methodological Guidelines, Programs, and Algorithms, Moscow (2007).
E. I. Gusev and V. I. Skvortsova, Cerebral Ischemia, Meditsina, Moscow (2001).
V. I. Skvortsova, “Ischemic stroke: pathogenesis of ischemia and therapeutic approaches,” Nevrol. Zh., 6, No. 3, 4–6 (2001).
A. I. Fedin and S. A. Rumyantseva, Intensive Therapy of Ischemic Stroke, Med. Kniga, Moscow (2004).
V. A. Parfenov, “Some aspects of the diagnosis and treatment of ischemic stroke,” Nevrol. Neiropsikh. Psikhosom., No. 1, 13–18 (2010).
S. A. Rumyantseva, A. L. Kovalenko, M. G. Romantsov, and O. S. Ketlinskaya, “Efficacy of Cytoflavin in the treatment of acute cerebrovascular accidents (a placebo-controlled study),” Vestn. St. Peterb. Gos. Med. Acad., No. 3, 97–98 (2004).
C. M. Butefisch, “Plasticity in the human cerebral cortex: lessons from the normal brain and from stroke,” Neuroscientist, 10, No. 2, 163–173 (2004), doi: https://doi.org/10.1177/1073858403262152.
N. S. Ward, “Mechanisms underlying recovery of motor function after stroke,” Postgrad. Med. J., 81, 510–514 (2005), doi: https://doi.org/10.1136/pgmj.2004.030809.
S. M. Vinichuk, “Diaschisis and its role in the development of reflex motor disorders in cerebral stroke,” Ukrain. Med. Zh., 94, No. 2, 143–147 (2013).
Z. A. Suslina and M. A. Piradov, Stroke: Diagnosis, Treatment, Prevention, MEDpress-Inform, Moscow (2008).
A. N. Bogolepova and E. I. Chukanova, “The problem of neuroplasticity in neurology,” Zh. Nevrol. Psikhiat., 110, No. 8, 72–75 (2010).
O. A. Gomazkov, The Pleiotropic Effects of Neurotrophins, KDM, Moscow (2010).
I. V. Damulin, “The main mechanisms of neuroplasticity and their clinical significance,” Zh. Nevrol. Psikhiat., 109, No. 4, 4–8 (2009).
D. F. Muresanu, “Neuroprotection and neuroplasticity – a holistic approach and perspective,” J. Neurol. Sci., 257, 38–43 (2007), doi:https://doi.org/10.1016/j.jns.2007.01.041.
N. V. Selyanina and Yu. V. Karakulova, “Activation of repair processes in the acute period of craniocerebral trauma with neurotrophic therapy,” Zh. Nevrol. Psikhiat., 112, No. 5, 46–49 (2012).
G. N. Bel’skaya and L. V. Luk’yanchikova, “Quality of life in patients with ischemic stroke in the vertebrobasilar system,” Zh. Nevrol. Psikhiat., 113, No. 12, Iss. 2, 24–28 (2013).
Yu. N. Klemesheva and O. N. Voskresenskaya, “Rehabilitation potential and its assessment in diseases of the nervous system,” Saratov. Nauch.-Med. Zh., No. 1, 120–123 (2009).
M. V. Putilina, “Neuroplasticity as the basis of the early rehabilitation of patients after stroke,” Zh. Nevrol. Psikhiat., 111, No. 12, 64–69 (2011).
S. A. Rumyantseva, V. V. Afanas’ev, and E. V. Silina, “The pathophysiological basis of complex neuroprotection in cerebral ischemia,” Zh. Nevrol. Psikhiat., 109, No. 3, 64–68 (2009).
E. V. Nikushkin, “Lipid peroxidation in the CNS in health and disease,” Neirokhimiya, 8, No. 1, 124–143 (1989).
M. M. Odinak, V. I. Skvortsova, I. A. Voznyuk, et al., “Assessment of the efficacy of Cytoflavin in patients during the acute period of ischemic stroke,” Zh. Nevrol. Psikhiat., No. 12, 4–8 (2010).
A. I. Fedin and S. A. Rumyantseva, “Current approaches to energycorrecting treatment of hypoxic brain damage,” Consilium Medicum, 9, No. 8, 104–105 (2007).
V. V. Koval’chuk, “Therapeutic potential for improving cognitive functions, psychoemotional status, and quality of life after stroke,” Zh. Nevrol. Psikhiat., 115, 92–97 (2015).
GOST R 52600.5-2008, Patient Management Protocol. Stroke, Standartinform, Moscow (2009).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 116, No. 8, Iss. 1, pp. 36–39, August, 2016.
Rights and permissions
About this article
Cite this article
Karakulova, Y.V., Selyanina, N.V., Zhelnin, A.V. et al. Effects of Antioxidant Treatment on Neurotrophins and Rehabilitation Processes Following Stroke. Neurosci Behav Physi 48, 54–57 (2018). https://doi.org/10.1007/s11055-017-0529-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-017-0529-5